Unknown

Dataset Information

0

Stress Granules and Neurodegenerative Disorders: A Scoping Review.


ABSTRACT: Cytoplasmic ribonucleoproteins called stress granules (SGs) are considered as one of the main cellular solutions against stress. Their temporary presence ends with stress relief. Any factor such as chronic stress or mutations in the structure of the components of SGs that lead to their permanent presence can affect their interactions with pathological aggregations and increase the degenerative effects. SGs involved in RNA mechanisms are important factors in the pathophysiology of neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS), frontotemporal degeneration (FTD), and Alzheimer's diseases (AD). Although many studies have been performed in the field of SGs and neurodegenerative disorders, so far, no systematic studies have been executed in this field. The purpose of this study is to provide a comprehensive perspective of all studies about the role of SGs in the pathogenesis of neurodegenerative disorders with a focus on the protein ingredients of these granules. This scoping review is based on a six-stage methodology structure and the PRISMA guideline. A systematic search of seven databases for qualified articles was conducted until December 2020. Publications were screened independently by two reviewers and quantitative and qualitative analysis was performed on the extracted data. Bioinformatics analysis was used to plot the network and predict interprotein interactions. In addition, GO analysis was performed. A total of 48 articles were identified that comply the inclusion criteria. Most studies on neurodegenerative diseases have been conducted on ALS, AD, and FTD using human post mortem tissues. Human derived cell line studies have been used only in ALS. A total 29 genes of protein components of SGs have been studied, the most important of which are TDP-43, TIA-1, PABP-1. Bioinformatics studies have predicted 15 proteins to interact with the protein components of SGs, which may be the constituents of SGs. Understanding the interactions between SGs and pathological aggregations in neurodegenerative diseases can provide new targets for treatment of these disorders.

SUBMITTER: Asadi MR 

PROVIDER: S-EPMC8261063 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8775509 | biostudies-literature
| S-EPMC8485071 | biostudies-literature
| S-EPMC11355037 | biostudies-literature
| S-EPMC8923828 | biostudies-literature
| S-EPMC7063561 | biostudies-literature
| S-EPMC5337522 | biostudies-literature
| S-EPMC7691274 | biostudies-literature
| S-EPMC10783645 | biostudies-literature
2019-03-15 | GSE125216 | GEO
| S-EPMC10354615 | biostudies-literature